Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant

Clinical trial NCT00880815 · COMPLETED

Trial details

NCT number: NCT00880815
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

CD20 Positive Chronic Lymphocytic Leukemia Follicular Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma Recurrent Diffuse Large B-Cell Lymphoma T-Cell Non-Hodgkin Lymphoma

Start date: 2009-02-17
Primary completion: 2019-05-28
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.